Your browser doesn't support javascript.
loading
Impact of TP53 on outcome of patients with myelofibrosis undergoing hematopoietic stem cell transplantation.
Gagelmann, Nico; Badbaran, Anita; Salit, Rachel B; Schroeder, Thomas; Gurnari, Carmelo; Pagliuca, Simona; Panagiota, Victoria; Rautenberg, Christina; Cassinat, Bruno; Thol, Felicitas; Wolschke, Christine; Robin, Marie; Heuser, Michael; Rubio, Marie-Thérèse; Maciejewski, Jaroslaw P; Reinhardt, Hans Christian; Scott, Bart L; Kröger, Nicolaus.
  • Gagelmann N; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Badbaran A; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Salit RB; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Schroeder T; Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital of Essen, Essen, Germany.
  • Gurnari C; Translational Hematology and Oncology Research Department, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH.
  • Pagliuca S; Department of Biomedicine and Prevention, Tor Vergata University of Rome, Rome, Italy.
  • Panagiota V; Department of Hematology, Brabois Hospital, Centre Hospitalier Régional Universitaire, Nancy, France.
  • Rautenberg C; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
  • Cassinat B; Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital of Essen, Essen, Germany.
  • Thol F; Laboratoire de Biologie Cellulaire, Hôpital Saint-Louis, Assistance Publique Hôpitaux de Paris, Paris, France.
  • Wolschke C; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
  • Robin M; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Heuser M; Service d'Hématologie-Greffe, Hôpital Saint-Louis, Assistance Publique Hôpitaux de Paris, Paris, France.
  • Rubio MT; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
  • Maciejewski JP; Department of Hematology, Brabois Hospital, Centre Hospitalier Régional Universitaire, Nancy, France.
  • Reinhardt HC; Translational Hematology and Oncology Research Department, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH.
  • Scott BL; Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.
  • Kröger N; Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital of Essen, Essen, Germany.
Blood ; 141(23): 2901-2911, 2023 06 08.
Article en En | MEDLINE | ID: mdl-36940410
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Mielofibrosis Primaria / Enfermedad Injerto contra Huésped Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Mielofibrosis Primaria / Enfermedad Injerto contra Huésped Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article